Company profile: Fractyl Health
1.1 - Company Overview
Company description
- Provider of curative therapies for metabolic diseases, including Revita, a therapy designed to modify duodenal dysfunction via hydrothermal ablation to restore metabolic health, and Rejuva, a preclinical AAV gene therapy platform aimed at improving islet function for long-term remission of T2D and obesity.
Products and services
- Curative Therapies for Metabolic Diseases: A biotechnology-driven portfolio that delivers curative therapies addressing metabolic diseases, spanning hydrothermal ablation of duodenal dysfunction and AAV gene transfer to improve islet function
- Rejuva Gene Therapy Platform: A preclinical, AAV-based platform that engineers in vivo gene transfer to improve islet function, targeting long-term remission of type 2 diabetes and obesity
- Revita: A hydrothermal ablation–based therapy that modifies duodenal dysfunction to restore metabolic health, focusing intervention on the duodenum to reestablish metabolic regulation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fractyl Health
Diasome
HQ: United States
Website
- Description: Provider of insulin-based, liver-targeted diabetes therapeutics utilizing Hepatocyte Directed Vesicles (HDV) to enhance insulin delivery and reduce hypoglycemia risk. The company conducts multiple Phase 2 studies, including OPTI-2 and ISLE-1 Phase 2b trials, the Good to Great study, and an insulin pump crossover study, evaluating HDV added to rapid-acting insulin in patients with Type 1 diabetes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diasome company profile →
Biodel
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics for the treatment of diabetes, focused on developing and commercializing diabetes treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biodel company profile →
Diabeloop
HQ: France
Website
- Description: Provider of automated insulin delivery and diabetes management solutions, developing closed-loop systems to automate treatment of type 1 diabetes, including DBLG1, an algorithm-driven system; DBL-hu for highly unstable type 1 diabetes; and DBL-4pen, a smartphone app with an auto-learning algorithm linked to a connected insulin pen and CGM.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diabeloop company profile →
Rubin Medical
HQ: Sweden
Website
- Description: Provider of diabetes aids for the public and healthcare sectors as a pharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rubin Medical company profile →
DeveloGen
HQ: Germany
Website
- Description: Provider of biology-driven drug discovery, developing novel therapies for diabetes and obesity. Founded in 1995 and based in Georgia, United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DeveloGen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fractyl Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fractyl Health
2.2 - Growth funds investing in similar companies to Fractyl Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fractyl Health
4.2 - Public trading comparable groups for Fractyl Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →